WuXi Biologics Denmark Finland Germany Netherlands Sweden United Kingdom New York China France

Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous drug substance (DS) manufacturing at pilot-scale. This advancement integrates industry-leading technologies, including membrane chromatography and automated control systems, along with iterative enhancements to Process Analytical Technology (PAT).View original content:https://www.prnewswire.co.uk/news-releases/wuxi-biologics-wuxiup-accomplishes-automated-continuous-drug-substance-production-at-pilot-scale-302527568.html